Research / ATEN / Fundamental state Inspectable configuration
State dimensions Filing 0001580808-26-000032 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
292.20% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
3.89% · OPTIONAL · VALID
Operating cash generation 5th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
2.97% · OPTIONAL · VALID
Revenue growth 75th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
13.40% · CORE · VALID
Inventory pressure 30th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
26.90% · OPTIONAL · VALID
Gross margin 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
79.63% · CORE · VALID
Operating margin 75th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
17.33% · CORE · VALID
R&D intensity 90th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
25.36% · OPTIONAL · VALID
SBC intensity 65th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
6.43% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 50 states Self-history eligible
Sep 30, 2021 8/8 normalized Level 3 Dec 31, 2021 8/8 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/9 normalized Level 3 Jun 30, 2025 6/7 normalized Level 3 Sep 30, 2025 8/9 normalized Level 3 Dec 31, 2025 8/9 normalized Level 3 Mar 31, 2026 8/9 normalized Level 3 Jun 30, 2026 8/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 75.30%
Current 292.20%
Delta 216.90% Capex Intensity Decreased
Previous 6.93%
Current 3.89%
Delta -3.03% Cash Generation Decreased
Previous 29.22%
Current 2.97%
Delta -26.24% Growth Increased
Previous 11.03%
Current 13.40%
Delta 2.37% Inventory Pressure Increased
Previous 6.21%
Current 26.90%
Delta 20.69% Margin Increased
Previous 79.34%
Current 79.63%
Delta 0.30% Profitability Increased
Previous 16.22%
Current 17.33%
Delta 1.11% R And D Intensity Increased
Previous 23.78%
Current 25.36%
Delta 1.57% Sbc Intensity Decreased
Previous 6.89%
Current 6.43%
Delta -0.47% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.